Omeros Corp (OMER.OQ)

OMER.OQ on NASDAQ Stock Exchange Global Market

10.60USD
4:00pm EDT
Price Change (% chg)

$-2.65 (-20.00%)
Prev Close
$13.25
Open
$11.10
Day's High
$11.25
Day's Low
$10.50
Volume
862,900
Avg. Vol
512,084
52-wk High
$13.45
52-wk Low
$3.16

OMER.OQ

Chart for OMER.OQ

About

Omeros Corporation, is a clinical-stage biopharmaceutical company. It is engaged in discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system. Its product candidates are derived from its PharmacoSurgerytm platform designed to improve clinical outcomes of... (more)

Overall

Beta: 1.04
Market Cap (Mil.): $297.49
Shares Outstanding (Mil.): 22.45
Dividend: --
Yield (%): --

Financials

  OMER.OQ Industry Sector
P/E (TTM): -- 49.13 43.38
EPS (TTM): -1.38 -- --
ROI: -176.18 10.38 9.53
ROE: -3,106.99 11.64 11.11
Search Stocks

Latest News about OMER.OQ

Omeros announces public offering of common stock

- Omeros Corp said it intends to raise cash from a public offering of its common stock, in part to fund the clinical development of two drugs that are in late-stage trials.

26 Jun 2012

UPDATE 1-Omeros announces public offering of common stock

June 26 - Omeros Corp said it intends to raise cash from a public offering of its common stock, in part to fund the clinical development of two drugs that are in late-stage trials.

26 Jun 2012
» More OMER.OQ News

Competitors

  Price Change
Pfizer Inc. (PFE.N) $22.61 +0.19
Johnson & Johnson (JNJ.N) $66.84 +0.42
Novartis AG (NOVN.VX) CHF52.80 +0.55
Merck & Co., Inc. (MRK.N) $40.53 +0.45
Roche Holding Ltd. (ROG.VX) CHF163.00 +0.30
Abbott Laboratories (ABT.N) $62.87 +0.52
Bayer AG (BAYGn.DE) €54.98 +1.67
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €58.13 +0.74
Eli Lilly & Co. (LLY.N) $41.93 +0.36

  Earnings  vs    Estimates

Analyst Research Reports

Report Title Price
Thomson Reuters Stock Report - OMEROS CORPORATION (OMER-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
ValuEngine Detailed Valuation Report for OMER
Provider: ValuEngine, Inc.
$127.00
Buy
OMEROS CORP (OMER) 2-weeks forecast
Provider: Pechala's Reports
$10.00
Buy
Omeros Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of OMEROS CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.
Provider: Jefferson Research
$127.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks